Skip to main content
  • MEETINGS
  • JOBS/RFPs
  • FUNDING
 

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Home

Summaries of Review for Applications to RFA 06-01

The following is a listing of all applications reviewed under RFA 06-01 for CIRM SEED Grants. Applications include the score (between 0 and 100, with 100 being the best) and a funding recommendation (indicated by the color key below) made by the Scientific and Medical Research Funding Working Group (SMRFWG) during the review meeting on November 28-30, 2006. A link to the Public Abstract (provided by applicant), Statement of Benefit to California (provided by applicant), and Public Review Report are available for each application by clicking on the respective application number.

 
= Recommended for funding
 
= Recommended if funds available
 
= Not Recommended  at this time

 Press release announcing grant approvals [pdf]

Application Number ICOC Decision Title Scientific Score
RS1-00205-1 Approved Generation of forebrain neurons from human embryonic stem cells 96
RS1-00210-1 Approved The APOBEC3 Gene Family as Guardians of Genome Stability in Human Embryonic Stem Cells 95
RS1-00305-1 Approved Generation of hESC lines, under defined conditions, modeling normal & diseased states from material stored at the Burnham shared embryo bank. 95
RS1-00288-1 Approved Gene regulatory mechanisms that control spinal neuron differentiation from hES cells. 94
RS1-00432-1 Approved Mitochondrial Dysfunction in Embryonic Stem Cells 93
RS1-00245-1 Approved Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells 92
RS1-00434-1 Approved Transcriptional Regulation of Human Embryonic Stem Cells 92
RS1-00365-1 Approved Profiling surface glycans and glycoprotein expression of human embryonic stem cells 92
RS1-00462-1 Approved MicroRNAs in Human Stem Cell Differentiation and Mental Disorders 91
RS1-00323-1 Approved Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency 91
RS1-00259-1 Approved Modeling Human Embryonic Development with Human Embryonic Stem Cells 91
RS1-00466-1 Approved Analysis of Candidate Neural Crest Cells Derived from Human ES Cells 91
RS1-00207-1 Approved Human Embryonic Stem Cell Differentiation to Trophoblast: Basic Biology and Clinical Translation to Improve Human Fertility 91
RS1-00404-1 Approved Patient-specific cells with nuclear transfer 91
RS1-00326-1 Approved In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction 91
RS1-00298-1 Approved Functions of RB family proteins in human embryonic stem cells 90
RS1-00280-1 Approved Generation of long-term cultures of human hematopoietic multipotent progenitors from embryonic stem cells 90
RS1-00271-1 Approved Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease 90
RS1-00313-1 Approved Role of Mitochondria in Self-Renewal Versus Differentiation of Human Embryonic Stem Cells 90
RS1-00198-1 Approved Specification of Ventricular Myocyte and Pacemaker Lineages Utilizing Human Embryonic Stem Cells 90
RS1-00228-1 Approved Derivation and Characterization of Cancer Stem Cells from Human ES Cells 89
RS1-00236-1 Approved Novel vectors for gene transfer into human ES cells 88
RS1-00163-1 Approved Programmed Cell Death Pathways Activated in Embryonic Stem Cells 88
RS1-00199-1 Approved Assessing the role of Eph/ephrin signaling in hESC growth and differentiation 88
RS1-00455-1 Approved Derivation and characterization of human ES cells from FSHD embryos 88
RS1-00319-1 Approved Reprogramming Differentiated Human Cells to a Pluripotent State 88
RS1-00327-1 Approved Self-renewal of human embryonic stem cells 88
RS1-00195-1 Approved Regulation of Specific Chromosomal Boundary Elements by CTCF Protein Complexes in Human Embryonic Stem Cells 88
RS1-00215-1 Approved Identifying small molecules that stimulate the differentiation of hESCs into dopamine-producing neurons 87
RS1-00243-1 Approved Differentiation of Human Embryonic Stem Cells to Intestinal Fates 87
RS1-00402-1 Approved Down-Regulation of Alloreactive Immune Responses to hES Cell-Derived Graft Tissues 86
RS1-00161-1 Approved MicroRNA Regulation of Human Embryonic Stem Cell Self-Renewal and Differentiation 86
RS1-00171-1 Approved Development of Neuro-Coupled Human Embryonic Stem Cell-Derived Cardiac Pacemaker Cells. 85
RS1-00420-1 Approved Improving microenvironments to promote hematopoietic stem cell development from human embryonic stem cells 85
RS1-00322-1 Approved In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity 85
RS1-00174-1 Approved A method to maintain and propagate pluripotent human ES cells 85
RS1-00289-1 Approved Stem Cell Survival and Differentiation Through Chemical Genetics 85
RS1-00444-1 Approved Role of the tumor suppressor gene, p16INK4a, in regulating stem cell phenotypes in embryonic stem cells and human epithelial cells. 84
RS1-00170-1 Approved In vitro differentiation of hESCs into corticospinal motor neurons 83
RS1-00249-1 Approved hESC as tools to investigate the neural crest origin of Ewing's sarcoma 82
RS1-00331-1 Approved Modeling Parkinson's Disease Using Human Embryonic Stem Cells 82
RS1-00222-1 Approved Therapeutic potential of Retinal Pigment Epithelial cell lines derived from hES cells for retinal degeneration. 81
RS1-00333-1 Approved Genetic manipulation of human embryonic stem cells and its application in studying CNS development and repair 81
RS1-00409-1 Approved Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination 81
RS1-00453-1 Approved Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells 78
RS1-00308-1 Approved Endodermal differentiation of human ES cells 72
RS1-00247-1 Approved Development of human ES cell lines as a model system for Alzheimer disease drug discovery 71
RS1-00416-1 Approved Production of Oocytes from Human ES Cells 83
RS1-00449-1 Approved Force, Dimensionality and Stem Cell Fate 82
RS1-00302-1 Approved A Chemical Approach to Stem Cell Biology 82
RS1-00225-1 Approved New Chemokine-Derived Therapeutics Targeting Stem Cell Migration 82
RS1-00173-1 Approved Combinatorial Platform for Optimizing Microenvironments to Control hESC Fate 81
RS1-00169-1 Approved Discovering Potent Molecules with Human ESCs to Treat Heart Disease 81
RS1-00292-1 Approved Mapping the transcriptional regulatory elements in the genome of hESC 81
RS1-00200-1 Approved Role of Glycans in Human Embryonic Stem Cell Conversion to Neural Precursor Cells 81
RS1-00428-1 Approved Sources of Genetic Instability in Human Embryonic Stem Cells. 80
RS1-00172-1 Approved Genetic modification of the human genome to resist HIV-1 infection and/or disease progression 80
RS1-00452-1 Approved Induction of pluripotency in fibroblasts by fusion with enucleated human embryonic stem cell syncytia 80
RS1-00203-1 Approved Genetic Enhancement of the Immune Response to Melanoma via hESC-derived T cells 79
RS1-00317-1 Approved Role of HDAC in human stem cells pluripotentiality and differentiation 79
RS1-00262-1 Approved Regulation of human neural progenitor cell proliferation by Ryk-mediated Wnt signaling 78
RS1-00283-1 Approved Trophoblast differentiation of human ES cells. 78
RS1-00381-1 Approved Labeling of human embryonic stem cells with iron oxide nanoparticles and fluorescent dyes for a non-invasive cell depiction with MR imaging and optical imaging 78
RS1-00387-1 -- Predifferentiation of human embryonic stem cells for CNS cortical applications 77
RS1-00477-1 Approved Non-coding RNA as tool for the active control of stem cell differentiation 77
RS1-00183-1 Approved EC regeneration in cerebrovascular ischemia: role of NO 77
RS1-00157-1 -- Physiological reactions to tumors in a mouse/hES cell model of brain cancer 77
RS1-00377-1 Approved The Immunological Niche: Effect of immunosuppressant drugs on stem cell proliferation, gene expression, and differentiation in a model of spinal cord injury. 77
RS1-00239-1 Approved Micro Platform for Controlled Cardiac Myocyte Differentiation 77
RS1-00242-1 Approved Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium 77
RS1-00413-1 Approved Using human embryonic stem cells to treat radiation-induced stem cell loss: Benefits vs cancer risk 77
RS1-00321-1 Approved Embryonic stem cell-derived thymic epithelial cells 76
RS1-00311-1 -- Use of small organic molecules to enhance, control, and understand survival and self renewal of human embryonic stem cells in vitro 76
RS1-00464-1 Approved hESCs for Articular Cartilage Regeneration 76
RS1-00185-1 -- Molecular Markers of Chondrogenesis 75
RS1-00408-1 Approved Screening for Oncogenic Epigenetic Alterations in Human ES Cells 75
RS1-00193-1 Approved Retinoic Acid-FGF Antagonism during Motor Neuron Differentiation of Human ES Cells 75
RS1-00180-1 -- Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells 74
RS1-00279-1 -- Chromosome instability due to telomere loss in human embryonic stem cells 74
RS1-00295-1 Approved In Vitro Differentiation of T cells from Human Embryonic Stem Cells. 74
RS1-00411-1 -- The role of HER2 signaling in differentiation and maintenance of human embryonic stem cells 74
RS1-00232-1 -- Role of Notch signaling in human embryonic stem cell differentiation to neuronal cell fates 73
RS1-00153-1 -- Control of neural stem-to-progenitor transitions by Cyclin D family members in ES cells 73
RS1-00219-1 -- Alteration of pre-mRNA splicing during stem cell differentiation 73
RS1-00360-1 -- Micropallet Arrays to Screen and Select Stem Cells 72
RS1-00159-1 -- Modeling leukemia stem cells using human ESC 72
RS1-00314-1 -- An Integrated Microfluidic Platform for Screening hESC Culture Conditions 71
RS1-00221-1 -- Elucidating Chemotropic Responses of Human Embryonic Stem Cells to Guidance Cues 71
RS1-00154-1 -- Increasing the number and survival of hESC and the derived lineages in tissue culture. --
RS1-00156-1 -- Designing monitoring systems for beta-cell differentiation from ES cells --
RS1-00160-1 -- Human embryonic stem cells for repairing stroke injuries in hippocampal slices. --
RS1-00162-1 -- In Vitro Differentiation of Human ES cells to Endoderm for Engraftment in Lung --
RS1-00164-1 -- Induction of cardiogenesis in human stem cells via chromatin remodeling --
RS1-00165-1 -- Genome Replacement in Human Embryonic Stem Cells --
RS1-00167-1 -- Characterization of Immune Responses in Human Embryonic Stem Cells --
RS1-00168-1 -- Blood formation from human ES cells --
RS1-00175-1 -- Assessing efficacy and safety of retro- and lentiviruses as gene therapy vectors in human embryonic stem cells --
RS1-00177-1 -- Prevalence and functional consequences of chromosomal mosaicism in hESC lines. --
RS1-00178-1 -- Pharmacological characterization of human stem cells and their differentiation via the GPCR transcriptome --
RS1-00179-1 -- High efficiency and high fidelity somatic cell nuclear reprogramming --
RS1-00181-1 -- SEED: Whole Stem Cell Sorting Using an All-Electronic Microfluidic System --
RS1-00182-1 -- Imaging and Tracking of Stem Cells In Vivo with Magnetic Particle Imaging --
RS1-00184-1 -- Nanotechnology Differentiation of Human Embryonic Stem Cells (hESCs) --
RS1-00186-1 -- Developing an Effective Stem Cell Gene Therapy to Treat Human Disease -- 
RS1-00187-1 -- Precursors isolated from human embryonic stem cell culture: potential use for kidney regeneration --
RS1-00188-1 -- DETERMINING THE ROLE OF MITOCHONDRIA IN THE REGULATION OF HUMAN EMBRYONIC STEM CELLS --
RS1-00189-1 -- Control of embryonic stem cell transcription by TGFb/Smad signaling --
RS1-00190-1 -- A HUMAN EMBRYONIC STEM CELL MODEL FOR THE DEVELOPMENT OF CD30-POSITIVE HODGKIN LYMPHOMA REED-STERNBERG CELLS (H-RS) --
RS1-00192-1 -- An Optimal Bioreactor For Production Of Erythrocytes From Human Embryonic Stem Cells --
RS1-00201-1 -- Regulation of human embryonic stem cell fate by different forms of the Polycomb transcriptional silencing machinery. --
RS1-00208-1 -- Mechanisms of hESC derived MSCs and BMSSCs to regenerate bone tissue --
RS1-00209-1 -- Development of the Stem Cell Matrix, a Shared Database of Stem Cell Information --
RS1-00211-1 -- The Use of Microfluidic Chambers and Microtechnology to Study hESC-derived Neural Cells --
RS1-00212-1 -- Targeting lentiviral vectors to modified hES derived dendritic cells --
RS1-00213-1 -- Generation of Inherited Disease Human Embryonic Stem Cell Lines --
RS1-00214-1 -- EFFECTS OF SMALL MOLECULE LIBRARIES ON DIFFERENTIATION OF EMBRYONIC AND NERAL STEMS CELLS IN DOPAMINERGIC PHENOTYPE --
RS1-00216-1 -- Metabolomic Signatures of Pluripotent Cell Lines --
RS1-00217-1 -- Instructive Biomaterials for Stem Cell Differentiation --
RS1-00218-1 -- Manipulation of Hedgehog signaling in early human embryos --
RS1-00223-1 -- Identification and Analysis of Genome-wide Intra- and Inter-chromosomal Associations in Human Embryonic Stem Cells --
RS1-00224-1 -- Genetic analysis and modification of hES cells --
RS1-00227-1 -- Formation of Personalized Embryonic Stem-Like Cells by In Vitro Epigenetic Cell Reprogramming --
RS1-00229-1 -- Developing chicken embryos as an experimental microenvironment for human embryonic stem cells --
RS1-00230-1 -- Brain Aging and hESC-derived Neural Stem Cell Transplantation --
RS1-00233-1 -- Epigenetic regulation of AAVS1 --
RS1-00234-1 -- Therapeutic potential of genetically modified human ES cells in an Alzheimer's disease model: Contribution of IGF-1 --
RS1-00237-1 -- Characterization and Modulation of the Natural Antibody-Mediated Immune Response to Human Embryonic Stem Cells --
RS1-00240-1 -- Analyzing myc function in human embryonic stem cells --
RS1-00241-1 -- Detection of Cell Lineages Among Stem Cell Progeny by microRNA Profiling --
RS1-00246-1 -- Stem Cell Lipid Organization --
RS1-00250-1 -- The Mammalian Stress Response and Human Embryonic Stem Cell Survival --
RS1-00252-1 -- Titanium Oxide Nanotube Platforms for Bioartificial Livers and for Transplantation of Hepatocytes Derived from Human Embryonic Stem Cells --
RS1-00253-1 -- Human embryonic stem cell-derived neurons as a model to discover safer estrogens for hot flashes --
RS1-00254-1 -- Therapeutic Potential of Transplanted human Embryonic Stem Cells Overexpressing Soluble APP in Treating Alzheimer's Disease --
RS1-00256-1 -- Therapeutic Potential of Human Embryonic Stem Cells: Cardiovascular Tissue Engineering --
RS1-00258-1 -- Derivation of Customized Stem Cells for Regenerative Medical Therapy -- 
RS1-00260-1 -- Stem Cell Transdifferentiation in the Testis --
RS1-00261-1 -- Analysis of the Mode of Division of Human Embryonic Stem Cells --
RS1-00265-1 -- Isolation of Human Lymphoid Progenitors and Induction to the B and T Cell Fates --
RS1-00266-1 -- Orthopaedic Applications of Human Embryonic Stem Cells. --
RS1-00267-1 -- Role of MYC and chromatin regulators in human embryonic stem cells --
RS1-00269-1 -- Interaction of BMP and polycomb pathways in human ES cell differentiation --
RS1-00270-1 -- Functional endothelial cells from human embryonic stem cells for therapeutic vasculogenesis --
RS1-00274-1 -- A novel approach for pancreatic beta-cell differentiation in vitro and in vivo --
RS1-00275-1 -- Neurogenesis in Alzheimer's Disease: A-beta, Friend or Foe? --
RS1-00276-1 -- Derivation and characterization of dopamine neurons from human embryonic stem cells --
RS1-00277-1 -- Comprehensive study of the osteogenic potential of human embryonic stem cells - are they equivalent to liposuctioned fat and bone marrow derived stem cells? --
RS1-00281-1 -- The Role of Ion Channels in the Differentiation of Embryonic Stem Cells --
RS1-00282-1 -- The Role of NF-kappaB in Human Embryonic Stem Cell Survival and Differentiation --
RS1-00287-1 -- Paracrine factor-mediated stem cell differentiation to cardiac myocytes --
RS1-00290-1 -- High Throughput for Small Molecule Probes of hESC Pluriopotency --
RS1-00294-1 -- Differentiation, Survival, and Function of hESC-Derived Cardiomyocytes --
RS1-00296-1 -- Engineering pluripotent hESC-like cells by genetic reprogramming of differentiating cells --
RS1-00297-1 -- Isolation of coronary progenitor cells from hESC --
RS1-00299-1 -- Anesthetic Effects on Neural Stem Cells --
RS1-00300-1 -- Engineering Bioactive Hydrogels for Neuronal Differentiation of hESCs --
RS1-00301-1 -- NOVEL REAGENTS TO CONTROL STEM CELL DIFFERENTIATION --
RS1-00303-1 -- Characterization of human embryonic stem cells in vivo in the SCID-hu mouse model. --
RS1-00304-1 -- Role of Liver-Enriched Transcription Factors in Differentiation of Human ES Cells --
RS1-00309-1 -- The consequences of chromosome imbalance: using a trisomic human embryonic stem cell line to determine the primary defects in individuals trisomic for chromosome 13 (Patau syndrome) --
RS1-00312-1 -- Characterization of factors involved in the regulation of chromatin structure and human stem cell pluripotency --
RS1-00315-1 -- Derivation of Human Embryonic Stem Cell-Like Cells from the Testis --
RS1-00318-1 -- MOLECULAR MECHANISMS OF CELL MOTILITY IN HUMAN NEURAL STEM CELLS --
RS1-00324-1 -- Establishment of human Embryonic Stem Cell Models to Study the Impact of Alzheimer's Disease Mutant Genes on Neuronal Functions --
RS1-00328-1 -- Characterization of MicroRNA (miRNA) Functions in Human Embryonic Stem Cells (hESCs) --
RS1-00329-1 -- Role of Ion Channels in Self-renewal and Fate Decisions of Human Embryonic Stem Cells --
RS1-00332-1 -- Human stem cell-derived motor neurons as an experimental model for ALS --
RS1-00334-1 -- Human Embryonic Stem Cells and Neural Crest Plasticity --
RS1-00335-1 -- Reconstruction of Pathways involved in cardiomyocyte differentiation from embryonic stem cells --
RS1-00336-1 -- Defining Heterogeneity of Human Embryonic Stem Cells --
RS1-00357-1 -- Establishment of human embryonic stem cell lines using re-constructed human embryos derived from polyspermic eggs --
RS1-00361-1 -- Telomerase and self-renewal in human embyronic stem cells --
RS1-00367-1 -- Magnetic Resonance Characteristics of CNS Changes Resulting from Targeted Human Embryonic Stem Cell Administration --
RS1-00368-1 -- A functional assessment of metabolic reconstruction in human embryonic stem cells --
RS1-00371-1 -- MHC-I suppression for long-term survival of hESC-derived oligodendrocytes and neurons --
RS1-00372-1 -- Genome-Wide High-Resolution Mapping of DNA Methylation in Human Embryonic Stem Cells --
RS1-00373-1 -- Generation of beta-cells from hepatocytes --
RS1-00374-1 -- Reversing age-imposed inhibition of stem cell regenerative potential --
RS1-00376-1 -- The control of cell movement and invasion in human embryoid bodies. --
RS1-00378-1 -- Exploring the Therapeutic Potential of Human Embryonic Stem Cells in Pediatric Neurotrauma --
RS1-00379-1 -- Cell-Cell Interactions Promote Differentiation of Human Embryonic Stem Cells to Insulin-Secreting Cells --
RS1-00380-1 -- Ovol genes and hES differentiation into hair-producing cells --
RS1-00382-1 -- Differentiation of Tooth Specific Cells --
RS1-00383-1 -- HLH Factors in Human Embryonic Stem Cells --
RS1-00384-1 -- Use of Human Embryonic Stem Cells for the Study of Myelin Regeneration --
RS1-00385-1 -- Engineering system platforms for human stem cell maintenance and differentiation --
RS1-00388-1 -- New Strategies to Understand Reprogramming Events in the Donor Nuclei Following Somatic Cell Nuclear Transfer --
RS1-00389-1 -- Adhesion Molecule Function in Human Hematopoietic Development --
RS1-00392-1 -- Stress response signaling pathways in hESCs --
RS1-00394-1 -- Directed Vasculogenic and Cardiogenic Differentiation of Embryonic Stem Cells --
RS1-00395-1 -- Differentiation of Stem Cells into ‘Systems of Neurotransmitter' Phenotypes Related to Alzheimer’s and Huntington’s Diseases: Application of High Throughput Peptidomic Approaches with Mass Spectrometry --
RS1-00397-1 -- Proteome-wide Profiling of Ubiquitination and Sumoylation in Human Embryonic Stem Cells --
RS1-00398-1 -- Study of TBX3 Function in human Embryo Stem (hES) Cell Differentiation and Identification of Genome-Wide TBX3 Promoter Binding-Sites with the CHIP-GLAS Promoter Array --
RS1-00399-1 -- Characterizing and identifying hESCs and their derivatives by Raman imaging --
RS1-00400-1 -- ENGINEERED MANIPULATIONS OF HUMAN EMBRYONIC STEM CELLS USING NANO-NEEDLES AND NANO-PARTICLES --
RS1-00403-1 -- Gene Targeting in Human ES Cells --
RS1-00405-1 -- Molecular Analysis of microRNAs in Pancreas Development --
RS1-00406-1 -- Assessment of the Immune Potential of Human Embryonic Stem Cells --
RS1-00407-1 -- Targeted Differentiation of Novel hESC Lines for Bladder Tissue Engineering Applications --
RS1-00412-1 -- Developmental Regulation of Human Embryonic Stem Cells by microRNAs --
RS1-00414-1 -- Treating Stress Urinary Incontinence with Human Embryonic Stem Cells --
RS1-00417-1 -- Derivation and Epigenomic Analysis of hES Cells --
RS1-00418-1 -- Stem cell therapy on hypertension: A potential source and role of nNOS in brainstem --
RS1-00419-1 -- 3D_SpineTracker - Automated remyelination detection and classification of axons for sub-acutely injured spinal cord section images for temporal tracking of remyelination after stem cell treatment --
RS1-00421-1 -- Optimized hESC Cultures Using Microfluidics --
RS1-00422-1 -- Development of Blood and Liver Stem Cells from Embryonic Stem Cells --
RS1-00425-1 -- hESC mitochondrial transfer to empower withered cardiomyocytes --
RS1-00427-1 -- Human Embryonic Stem Cell Therapy for Retinal Degeneration --
RS1-00429-1 -- Treatment of Lung Disease with Inhaled Stem Cells --
RS1-00431-1 -- Differentiation of Human Embryonic Stem Cells to Heart Cells --
RS1-00435-1 -- Derivation of New Human Embryonic Cell Lines in Full Compliance with Current FDA Regulatory Guidance --
RS1-00436-1 -- Fate and connectivity of HESCs in temporal lobe disorders. --
RS1-00439-1 -- Proteomics of the Oxidative Stress Response in Embryonic Stem Cells --
RS1-00440-1 -- Optimizing human embryonic stem cell-derived neural stem/progenitor cells for stroke cell therapy --
RS1-00441-1 -- Selecting Embryonic Cell-Derived Cardiomyocytes by Specific Surface Marker --
RS1-00442-1 -- Integrin ligation in human ESC (hESC) proliferation and fate determination --
RS1-00450-1 -- Control of Herpes Simplex Virus latency by cellular DNA repair proteins --
RS1-00451-1 -- Development of a novel human embryonic stem cell (hESC) model of familial amyotrophic lateral sclerosis (ALS) --
RS1-00457-1 -- Role of RXR in Nurr1-induced Differentiation of Human ES Cells and in Parkinson's Disease --
RS1-00458-1 -- Role of PK2 on the differentiation of human neural stem cells and ischemia-induced neurogenesis --
RS1-00461-1 -- MicroRNAs in Human Embryonic Stem Cell Self-Renewal and Differentiation --
RS1-00463-1 -- Alternative splicing during neural differentiation of human embryonic stem cells. --
RS1-00465-1 -- A novel live study in a 3-D microfluidic model using multicolored quantum dot(QD) tagged probes: for imaging multiple protein(s) interactions whether activators/inhibitors or "bind / non-bind" using surface-enhanced Raman spectroscopy (SERS), multiphoton microscope (MPM) and Laser Tweezer. --
RS1-00468-1 -- Genetic manipulation of human embryonic stem cells by lentiviral vectors. --
RS1-00469-1 -- Directed differentiation of hES cells into the heart valve lineage --
RS1-00470-1 -- Creating Human Embryonic Stem Cell Lines Containing Multiple Sclerosis Genomes via Cell Fusion --
RS1-00471-1 -- Effect of Tumor Necrosis Factor Alpha on Stem Cell Fate Determination in the Central Nervous System --
RS1-00472-1 -- Modulation of Stem Cell PTHrP/Wnt Signaling to Prevent Chronic Lung Disease --
RS1-00473-1 -- Regenerative CF Airway Epithelium by Embryonic Stem Cells --
RS1-00474-1 -- Pericellular proteolysis in human ES cell differentiation and tumorigenesis --
RS1-00480-1 -- Regulation of apoptosis during endocrine development --

 

Newsletter Sign-Up

Receive press releases, funding announcements or other news from CIRM.

>> Click here to sign up

Follow Us

Facebook Updates
YouTube Videos
Twitter
Flickr Images
LinkedIn
Research Blog
RSS Feeds

 

« February 2012 »
MonTueWedThuFriSatSun
12345
6789101112
13141516171819
20212223242526
272829
Bookmark and Share
  • Contact Us
  • Privacy Policy
  • Accessibility
  • Site Map
© 2009 California Institute For Regenerative Medicine